The Federal Trade Commission’s “Second Interim Staff Report” on pharmacy benefit managers (PBMs) has generated headlines and political momentum, painting a picture of rampant profiteering by the three largest PBMs — CVS Caremark, Express Scripts and OptumRx. The report focuses on what its authors allege to be huge markups for a set of specialty generic drugs and […]
Author Archives: Anthony T. LoSasso
Tony LoSasso is a professor and chair of the economics department at DePaul University. He wrote this for InsideSources.com.
